Patricia Hughes, Ph.D., has been appointed head of Sales and Business
Development for the office, responsible for market development, sales,
and
customer service throughout Europe.
Mitchell
R. Butier succeeds Daniel R. O’Bryant as chief financial officer; vice president and controller Lori J.
Bondar will take over as chief accounting officer.
Keith
Wilkinson’s global business development responsibilities in the
Specialty
Chemicals business segment have increased, while Guillaume Saint Clair
will be
responsible for managing both the company’s pharmaceutical intermediates
business and the specialty chemicals business overseas.